Loading
This study tests TROP-2-directed treatment; the registry reports that it is terminated.
The registry lists NCT02122146 as terminated, last updated 2018-02-19. Enrolment is 31 actual participants. Interventions: PF-06664178. Primary measures include First Cycle Dose Limiting Toxicities (DLTs) In Order to Determine the Maximum Tolerated Dose(MTD); Number of Patients With All-Causality Treatment-Emergent Adverse Events(TEAEs) [Part 2 & 3]. The registry reason for stopping is: The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results. Results are posted in the registry.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/